Genesis Electrical Impedance Tomography (EIT): A Preliminary Study

Description

The purpose of this study is to evaluate the Genesis Electrical Impedance Tomography (EIT) imaging system for use in pediatric respiratory disease populations including neuromuscular and bronchopulmonary dysplasia, as well as in age and height matched controls. The EIT does not use radiation, and is read through electrodes.

Conditions

Premature Infant, Chronic Respiratory Disease, Neuromuscular Diseases, Healthy, Bronchopulmonary Dysplasia, Pulmonary Vein Stenoses

Talk to us

Study Overview

On this page

Study Details

Study overview

The purpose of this study is to evaluate the Genesis Electrical Impedance Tomography (EIT) imaging system for use in pediatric respiratory disease populations including neuromuscular and bronchopulmonary dysplasia, as well as in age and height matched controls. The EIT does not use radiation, and is read through electrodes.

The Associations Between EIT and Clinical Measures During Standard of Care Procedures in Patients With Respiratory Disease: A Preliminary Study

Genesis Electrical Impedance Tomography (EIT): A Preliminary Study

Condition
Premature Infant
Intervention / Treatment

-

Contacts and Locations

Aurora

Children's Hospital Colorado, Aurora, Colorado, United States, 80045

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * 2 weeks old - 40 years old
  • * Premature infants with current age \>2 weeks with a confirmed diagnosis of BPD based on NIH criteria
  • * Or Chronic respiratory disease due to underlying neuromuscular disease
  • * Or confirmed neuromuscular disease with an echo completed within the preceding 12 months of study participation of DMD or other diagnoses associated with mild cardiomyopathy.
  • * have had a VQ scan
  • * will be undergoing cardiac catherization for for pulmonary vein stenosis, pulmonary hypertension and/or pulmonary artery stenosis
  • * Or healthy controls
  • * \<2 weeks of age
  • * Congenital diaphragmatic hernia
  • * Severe congenital heart disease
  • * Significant genetic abnoralities
  • * Anything that interferes with lead placement on the chest wall
  • * Unwilling/refusal to sign consent
  • * Pregnant or lactating
  • * Pacemaker of other surgical implant and spinal implant (causes noise in the data)
  • * Moderate to severe cardiomyopathy
  • * Patients with temporary cognitive disability due to illness

Ages Eligible for Study

14 Days to 40 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

University of Colorado, Denver,

Study Record Dates

2024-11-30